A. J. Leikas

Intramyocardial adenoviral vascular endothelial growth factor‐D∆N∆C gene therapy does not induce ventricular arrhythmias

J. Hartikainen, S. Ylä-Herttuala, H. Mussalo, 2022, The journal of gene medicine.

Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-DΔNΔC gene therapy eight-year follow-up of phase I KAT301 study

J. Hartikainen, S. Ylä-Herttuala, A. Hedman, 2021, Gene Therapy.

Efficacy and Safety of Clinical Grade hVEGF-DΔNΔC Gene Therapy Containing Residual Replication-Competent Adenoviruses.

J. Hartikainen, S. Ylä-Herttuala, N. Laham-Karam, 2020, Human gene therapy.

Adenoviral Gene Therapy Vectors in Clinical Use—Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety

A. J. Leikas, S. Ylä-Herttuala, Juha E. K. Hartikainen, 2023, International journal of molecular sciences.